Mevalonate Metabolism Regulates Basal Breast Cancer Stem Cells and Is a Potential Therapeutic TargetChristophe Ginestier, Emmanuelle Charafe‐Jauffret|Stem Cells|2012Cited by 145
MiR-662 is associated with metastatic relapse in early-stage breast cancer and promotes metastasis by stimulating cancer cell stemnessMargherita Puppo, Philippe Clézardin, Martine Croset et al.|British Journal of Cancer|2023Cited by 8